Equity / Capital Stock / Earnings per Share (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Equity [Abstract] |
|
| Schedule of stockholders equity |
As of December 31, 2025, and December 31,
2024, the following classes and series of capital stock were authorized and issued and outstanding. The table below also summarizes
the par value, voting rights, and conversion terms applicable to each class and series.
Schedule of stockholders equity
| Series |
Par
Value |
Authorized |
|
Outstanding
12/31/2025 |
Outstanding
12/31/2024 |
Votes Per
Share |
Conversion
Ratio |
| Common |
No par |
20,000,000,000 |
|
6,211,776,842 |
4,347,776,842 |
1 vote per share |
N/A |
| Series A |
No par |
105,000 |
|
105,000 |
105,000 |
3,000 votes per share |
None |
| Series B |
No par |
33,000 |
|
13,500 |
13,500 |
1,000 votes per share |
1 : 1,000 |
| Series C |
No par |
100,000 |
|
9,404 |
8,249 |
400,000 votes per share |
1 : 400,000 |
| Series D |
$25 par |
35,000 |
|
0 |
700 |
25,000 votes per share |
1 : 25,000 |
| Series NMC |
$25 par |
7,100,000 |
|
6,900,000 |
6,900,000 |
500 votes per share |
1 : 500 |
| Undesignated Preferred Stock |
No par |
42,627,000 |
|
0 |
0 |
N/A |
N/A |
|
| Schedule of instruments |
Schedule of instruments
| Instrument |
Instruments
Outstanding |
Common Shares
Issuable per Instrument |
Total Common Shares
Issuable |
| Series C contractual purchase rights (bespoke options) |
1,861 |
400,000 |
744,400,000 |
| Series C warrants |
2,750 |
400,000 |
1,100,000,000 |
| Series D warrants |
60,000 |
25,000 |
1,500,000,000 |
| Series NMC warrants |
6,900,000 |
500 |
3,450,000,000 |
| Total |
— |
— |
6,794,400,000 |
|
| Schedule of preferred stock outstanding |
Schedule of preferred stock outstanding
| Series |
Preferred
Shares
Outstanding |
Conversion
Ratio (Common
per Preferred) |
Common Shares
Issuable |
| Series B Convertible Preferred Stock |
13,500 |
1,000 |
13,500,000 |
| Series C Convertible Preferred Stock |
9,404 |
400,000 |
3,761,600,000 |
| Series NMC Convertible Preferred Stock |
6,900,000 |
500 |
3,450,000,000 |
| Total |
— |
— |
7,225,100,000 |
|
| Schedule of earnings per share |
Schedule of earnings per share
| |
Year
Ended December 31, 2025 |
Year
Ended December 31, 2024 |
| Net
income (loss) |
$(291,519) |
$396,762 |
Less:
Series A preferred dividend
|
—
|
$(10,500)
|
Net
income (loss) attributable to common stockholders
|
$(291,519)
|
$386,262
|
| Weighted
average shares – basic |
4,835,385,747 |
4,352,178,005 |
| Basic
earnings (loss) per share |
$(0.00006) |
$0.000089 |
| Weighted
average shares – diluted |
4,835,385,747 |
5,953,338,005 |
| Diluted
earnings (loss) per share |
$(0.00006) |
$0.000065 |
|